Canaccord Genuity Group Issues Positive Forecast for Heartflow (NASDAQ:HTFL) Stock Price

Heartflow (NASDAQ:HTFL) had its price objective raised by Canaccord Genuity Group from $56.00 to $69.00 in a report published on Friday,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock.

HTFL has been the subject of several other reports. Robert W. Baird boosted their target price on Heartflow from $56.00 to $68.00 and gave the stock an “outperform” rating in a research report on Friday. Stifel Nicolaus lifted their price objective on shares of Heartflow from $45.00 to $70.00 and gave the stock a “buy” rating in a research note on Friday. JPMorgan Chase & Co. boosted their price objective on shares of Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a report on Friday, August 14th. Wall Street Zen downgraded shares of Heartflow from a “buy” rating to a “hold” rating in a research note on Saturday, November 7th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Heartflow in a report on Wednesday, November 4th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $60.12.

Heartflow Trading Down 19.1%

Shares of HTFL traded down $11.46 on Friday, reaching $48.46. 3,705,135 shares of the company’s stock were exchanged, compared to its average volume of 1,763,967. The business has a 50 day moving average price of $51.91 and a two-hundred day moving average price of $35.23. Heartflow has a 12 month low of $20.13 and a 12 month high of $60.65. The stock has a market capitalization of $4.21 billion, a P/E ratio of -52.67 and a beta of 2.50.

Heartflow (NASDAQ:HTFL) last released its quarterly earnings data on Thursday, November 12th. The company reported ($0.03) EPS for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.15. Heartflow had a negative return on equity of 20.42% and a negative net margin of 33.11%. The business had revenue of $72.86 million during the quarter. During the same quarter in the prior year, the company posted ($0.27) EPS. Equities research analysts predict that Heartflow will post -0.75 EPS for the current year.

Insider Transactions at Heartflow

In other news, CFO Vikram Verghese sold 3,587 shares of Heartflow stock in a transaction dated Monday, November 9th. The stock was sold at an average price of $53.15, for a total transaction of $190,649.05. Following the transaction, the chief financial officer owned 149,587 shares in the company, valued at $7,950,549.05. The trade was a 2.34% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Campbell Rogers sold 23,933 shares of Heartflow stock in a transaction dated Thursday, October 22nd. The shares were sold at an average price of $55.01, for a total value of $1,316,554.33. Following the transaction, the insider owned 73,453 shares in the company, valued at $4,040,649.53. This trade represents a 24.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 332,403 shares of company stock valued at $16,602,786 over the last 90 days. 7.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. XXEC Inc. acquired a new position in shares of Heartflow in the second quarter valued at approximately $2,524,764,000. BlackRock Inc. acquired a new stake in shares of Heartflow during the second quarter worth $152,502,000. Bamco Inc. NY acquired a new stake in shares of Heartflow during the second quarter worth $94,625,000. Jupiter Topco LLC acquired a new stake in shares of Heartflow during the second quarter worth $70,983,000. Finally, Janus Henderson Group PLC lifted its position in Heartflow by 152.0% in the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock valued at $53,063,000 after acquiring an additional 1,315,416 shares in the last quarter.

Heartflow News Roundup

Investors following HTFL have been watching these news items:

• Positive Sentiment: Heartflow raised its 2026 revenue guidance to $262 million–$264 million, above the approximately $248.5 million consensus, signaling stronger expected growth. Financial results and guidance
• Positive Sentiment: Wells Fargo, Canaccord Genuity, Stifel and Baird raised their price targets to $68–$70 and maintained positive ratings, reflecting improved analyst expectations. Wells Fargo rating Canaccord Genuity rating Stifel rating Baird rating
• Negative Sentiment: A report said Heartflow’s CEO sold about $2.17 million worth of stock. Insider selling can concern investors, though the report alone does not establish the reason for the sale. CEO stock sale

Heartflow Company Profile

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.